Related Experiment Videos
Which medications are suitable for agonist drug maintenance?
Shane Darke1, Michael Farrell1
1National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
Addiction (Abingdon, England)
|October 28, 2015
Summary
Opioids and nicotine show promise as agonist maintenance treatments, meeting all criteria. While nicotine and cannabis have potential, further research is needed for long-term cognitive effects.
Area of Science:
- Addiction medicine
- Pharmacology
- Neuroscience
Background:
- Agonist maintenance treatment is a key strategy for managing psychoactive drug dependence.
- Evaluating the suitability of various drug classes for this treatment is crucial for effective addiction management.
Purpose of the Study:
- To assess the feasibility of agonist maintenance therapy for major psychoactive drug classes.
- To determine which drug classes possess the necessary pharmacological and neurocognitive properties for successful maintenance treatment.
Main Methods:
- Eight clinical criteria were used to evaluate drug classes: pharmacological aspects (agonist, stability, dose-response, non-toxicity) and neurocognitive sequelae (psychiatric, cognitive, craving, salience).
- Each major drug class (opioids, nicotine, benzodiazepines, cannabis, psychostimulants, alcohol) was assessed against these eight criteria.
Main Results:
- Opioids and nicotine met all eight criteria, indicating strong potential for maintenance therapy.
- Cannabis (five criteria) and benzodiazepines (five criteria) showed partial suitability, with caveats regarding long-term cognitive effects and safe administration.
- Psychostimulants (three criteria) and alcohol (one criterion) were deemed poor candidates due to unfavorable pharmacological and neurocognitive profiles.
Conclusions:
- Drug classes differ significantly in their suitability for agonist maintenance treatment.
- Nicotine and cannabis, though not widely used currently, demonstrate potential for future maintenance roles.
- The inherent properties of certain drug classes make them unsuitable for agonist maintenance regimens.